Browsing Tag
Abivax
2 posts
Valerio Therapeutics and Abivax target next-generation therapies for inflammatory disease
Valerio may gain cash and platform validation from Abivax, but definitive terms and preclinical delivery will decide whether the alliance creates value.
July 16, 2026
Abivax (NASDAQ: ABVX) obefazimod NDA path meets a safety debate the market is still pricing
Abivax (NASDAQ: ABVX) put up Rinvoq-like ulcerative colitis remission data and dropped 40 percent. The question is whether the malignancy debate sticks.
June 21, 2026